$28.43
0.682.45%
At close: -
$28.43
00.00%
After Hours: 1:00 PM EDT
Comments
Loading...
Spyre Therapeutics (NASDAQ:SYRE) Stock, Earnings Estimates, EPS, And Revenue
Spyre Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 27
EPS Estimate
$-0.760
Quarterly Revenue Estimate
$3.5M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Spyre Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Spyre Therapeutics (SYRE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-07 | $-1.36 | $-0.83 | -63.9 % |
| Jun 2024 | 2024-08-07 | $-0.86 | $-0.95 | 9.47 % |
| Mar 2024 | 2024-05-09 | $-1.20 | $-1.17 | -2.56 % |
| Dec 2023 | 2024-02-29 | $-4.05 | $-0.78 | -419.2 % |
Spyre Therapeutics (SYRE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-02-29 | $0 | $220.00K | -100.0 % |
| Jun 2023 | 2023-08-11 | $688.00K | $200.00K | 244.0 % |
| Mar 2023 | 2023-05-11 | $198.00K | $120.00K | 65.0 % |
| Dec 2022 | 2023-03-02 | $168.00K | $60.00K | 180.0 % |
FAQ
When is Spyre Therapeutics (NASDAQ:SYRE) reporting earnings?
Spyre Therapeutics (SYRE) is scheduled to report earnings on February 27, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for Spyre Therapeutics (NASDAQ:SYRE)?
The Actual EPS was $-1.36, which missed the estimate of $-0.83.
What were Spyre Therapeutics’s (NASDAQ:SYRE) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.